The use of G-SCF prophylaxis and antibiotic prophylaxis for FN was at the discretion of the treating physician in our study; however, 11 (22%) patients receiving primary or secondary prophylaxis with G-CSF showed a decreased rate of neutropenia. This evidence concerns the gene KITLG and Decreased total neutrophil count.